BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11122159)

  • 1. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
    Griesshammer M; Bangerter M; Schrezenmeier H
    Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia.
    Randi ML; Putti MC; Pacquola E; Luzzatto G; Zanesco L; Fabris F
    Pediatr Blood Cancer; 2005 Jan; 44(1):47-50. PubMed ID: 15390356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
    Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
    Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
    Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
    Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.
    Horikawa Y; Matsumura I; Hashimoto K; Shiraga M; Kosugi S; Tadokoro S; Kato T; Miyazaki H; Tomiyama Y; Kurata Y; Matsuzawa Y; Kanakura Y
    Blood; 1997 Nov; 90(10):4031-8. PubMed ID: 9354672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel thrombopoietin signaling defect in polycythemia vera platelets.
    Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
    Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
    Geddis AE; Fox NE; Kaushansky K
    Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
    Li J; Sabath DF; Kuter DJ
    Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
    Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
    Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat.
    Yang C; Li YC; Kuter DJ
    Br J Haematol; 1999 May; 105(2):478-85. PubMed ID: 10233424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
    Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
    Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
    Chen Q; Solar G; Eaton DL; de Sauvage FJ
    Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial serum thrombopoietin levels in a pregnant woman with essential thrombocythaemia.
    Kanda Y; Chiba S; Tanaka Y; Miwa A; Togawa A; Kato T; Miyazaki H; Nishino R; Yazaki Y; Hirai H
    Br J Haematol; 1999 Apr; 105(1):271-3. PubMed ID: 10233392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin in patients with hepatoblastoma.
    Komura E; Matsumura T; Kato T; Tahara T; Tsunoda Y; Sawada T
    Stem Cells; 1998; 16(5):329-33. PubMed ID: 9766812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.
    Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ
    Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
    Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
    Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.